These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10374223)

  • 41. [Gestagen supplementation to estrogen therapy in climacteric].
    Iversen OE
    Tidsskr Nor Laegeforen; 2001 Jan; 121(1):82-3. PubMed ID: 12013622
    [No Abstract]   [Full Text] [Related]  

  • 42. Counseling postmenopausal women about preventive hormone therapy. AGS Clinical Practice Committee.
    J Am Geriatr Soc; 1996 Sep; 44(9):1120-2. PubMed ID: 8790245
    [No Abstract]   [Full Text] [Related]  

  • 43. Initial treatment of dysfunctional uterine bleeding with estrogen--progestin combination.
    Mansuwan K
    J Med Assoc Thai; 1980 Jan; 63(1):6-10. PubMed ID: 7359057
    [No Abstract]   [Full Text] [Related]  

  • 44. [Therapeutic results obtained from women with functional sterility. First communication: combined oestrogen-gestagen therapy (author's transl)].
    Weise W; Schönijahn A; Prügel P
    Zentralbl Gynakol; 1982; 104(1):2-8. PubMed ID: 6807007
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Hormone substitution following transcervical endometrial ablation].
    Römer T
    Zentralbl Gynakol; 1997; 119(5):229-31. PubMed ID: 9281257
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Gestagen supplementation].
    Ims L
    Tidsskr Nor Laegeforen; 2001 Feb; 121(5):629-30. PubMed ID: 11301629
    [No Abstract]   [Full Text] [Related]  

  • 47. [Juvenilna Metroragija].
    Grubisić Z; Mitrović B
    Jugosl Ginekol Opstet; 1976; 16(2):115-9. PubMed ID: 979328
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Women's opinion on withdrawal bleeding with hormone replacement therapy.
    Barentsen R; Groeneveld FP; Bareman FP; Hoes AW; Dokter HJ; Drogendijk AC
    Eur J Obstet Gynecol Reprod Biol; 1993 Oct; 51(3):203-7. PubMed ID: 8288016
    [TBL] [Abstract][Full Text] [Related]  

  • 49. On menstrual bleeding with hormone replacement therapy.
    Rees M
    Lancet; 1994 Jan; 343(8892):250. PubMed ID: 7905092
    [No Abstract]   [Full Text] [Related]  

  • 50. [Estrogen-gestagen therapy with hormonally induced uterine bleeding. II. Therapeutic use of Klimovan].
    Cséffalvay T; Klose S
    Dtsch Gesundheitsw; 1965 Jul; 20(29):1334-9. PubMed ID: 5319408
    [No Abstract]   [Full Text] [Related]  

  • 51. [Influence of hormone substitution therapy on postmenopausal uterus].
    Otte A; Rüdisüli A; Goetze M; Leibundgut U; Nitzsche EU; Müller-Brand J
    Nuklearmedizin; 1997 Dec; 36(8):295-7. PubMed ID: 17068882
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Estrogens and cartilage: an ex vivo ultrastructural study].
    Fioravanti A; Ruozi P; Bellisai F; Marcolongo R
    Minerva Med; 1995 Apr; 86(4):143-8. PubMed ID: 7623970
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The role of vaginal smears in the follow-up od menopausal symptoms].
    Szántó F
    Orv Hetil; 1998 Mar; 139(12):693-5. PubMed ID: 9555166
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [On the effectiveness of a new gestagen in the treatment of bleeding anomalies. A clinical contribution to the problem of oral gestagen therapie].
    Thewanger W
    Wien Klin Wochenschr; 1965 Jun; 77(25):468-9. PubMed ID: 5319349
    [No Abstract]   [Full Text] [Related]  

  • 55. [The current status of gestagen administration. 1. Introduction, gestagens in gynecology].
    Völker W
    Fortschr Med; 1977 Jan; 95(1):15-9. PubMed ID: 832824
    [No Abstract]   [Full Text] [Related]  

  • 56. [Guidelines for estrogen and gestagen replacement in the climacteric and postmenopause. The 21st work meeting of the Zurich Discussion Group, November, 1998].
    Birkhäuser M; Braendle W; Breckwoldt M; Keller PJ; Kuhl H; Runnebaum B
    Gynakol Geburtshilfliche Rundsch; 1999; 39(3):133-5. PubMed ID: 10420057
    [No Abstract]   [Full Text] [Related]  

  • 57. Bleeding patterns of the hormone replacement therapies in the postmenopausal estrogen and progestin interventions trial.
    Simon JA; Symons JP
    Obstet Gynecol; 2003 May; 101(5 Pt 1):1020; author reply 1020-1. PubMed ID: 12738166
    [No Abstract]   [Full Text] [Related]  

  • 58. Improving continuation rates for hormone replacement therapy.
    Gambrell RD
    Menopause; 2002; 9(1):3-5. PubMed ID: 11791080
    [No Abstract]   [Full Text] [Related]  

  • 59. [Hormone therapy of endometriosis--principles and clinical aspects of gestagen treatment].
    Köhler G
    Zentralbl Gynakol; 1995; 117 Suppl():6-13. PubMed ID: 8571691
    [No Abstract]   [Full Text] [Related]  

  • 60. Progestin challenge test in postmenopausal patients.
    Valenzuela P; Sabatel RM; Valls V; Nieto A; Gonzalez-Gomez F
    Int J Gynaecol Obstet; 1993 Dec; 43(3):313-6. PubMed ID: 7907043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.